Manulife (Manufacturers Life Insurance)
ACAD icon

Manulife (Manufacturers Life Insurance)’s Acadia Pharmaceuticals ACAD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7M Buy
571,776
+39,243
+7% +$938K 0.01% 749
2025
Q4 		$14.2M Sell
532,533
-1,578
-0.3% -$37.7K 0.01% 741
2025
Q3 		$11.4M Sell
534,111
-253,413
-32% -$5.99M 0.01% 801
2025
Q2 		$17M Sell
787,524
-16,595
-2% -$308K 0.02% 653
2025
Q1 		$13.4M Buy
804,119
+176,103
+28% +$3.2M 0.01% 721
2024
Q4 		$11.5M Buy
628,016
+214,747
+52% +$3.47M 0.01% 813
2024
Q3 		$6.36M Sell
413,269
-48,809
-11% -$814K 0.01% 1108
2024
Q2 		$7.51M Sell
462,078
-709,546
-61% -$11.5M 0.01% 959
2024
Q1 		$21.7M Buy
1,171,624
+325,596
+38% +$8.07M 0.02% 603
2023
Q4 		$26.5M Sell
846,028
-204,366
-19% -$4.88M 0.02% 533
2023
Q3 		$21.9M Buy
1,050,394
+137,369
+15% +$3.73M 0.01% 566
2023
Q2 		$21.9M Buy
913,025
+40,975
+5% +$911K 0.01% 570
2023
Q1 		$16.4M Sell
872,050
-57,227
-6% -$1.09M 0.01% 656
2022
Q4 		$14.8M Buy
929,277
+12,879
+1% +$201K 0.01% 675
2022
Q3 		$15M Buy
916,398
+11,385
+1% +$184K 0.01% 674
2022
Q2 		$12.8M Buy
905,013
+29,891
+3% +$558K 0.01% 740
2022
Q1 		$21.2M Buy
875,122
+81,222
+10% +$1.97M 0.01% 648
2021
Q4 		$18.5K Sell
793,900
-226,360
-22% -$4.55M 0.01% 694
2021
Q3 		$16.9M Buy
1,020,260
+30,447
+3% +$587K 0.01% 720
2021
Q2 		$24.1M Buy
989,813
+380,003
+62% +$8.58M 0.02% 594
2021
Q1 		$15.7M Buy
609,810
+326,895
+116% +$14.4M 0.01% 762
2020
Q4 		$15.1M Buy
+282,915
New +$14M 0.01% 716
2020
Q2 		– Sell
-72,006
Closed -$3.04M – 2838
2020
Q1 		$3.04M Buy
72,006
+8,074
+13% +$333K ﹤0.01% 1186
2019
Q4 		$2.73M Sell
63,932
-2,013
-3% -$87.6K ﹤0.01% 1332
2019
Q3 		$2.42M Sell
65,945
-79
-0.1% -$2.4K ﹤0.01% 1332
2019
Q2 		$1.76M Sell
66,024
-8,114
-11% -$207K ﹤0.01% 1415
2019
Q1 		$1.99M Buy
74,138
+13,082
+21% +$306K ﹤0.01% 1417
2018
Q4 		$987K Buy
61,056
+32,282
+112% +$627K ﹤0.01% 1589
2018
Q3 		$597K Sell
28,774
-46,040
-62% -$724K ﹤0.01% 2151
2018
Q2 		$1.14M Sell
74,814
-62,166
-45% -$1.11M ﹤0.01% 1783
2018
Q1 		$3.08M Buy
136,980
+132,946
+3,296% +$3.68M ﹤0.01% 1369
2017
Q4 		$121K Sell
4,034
-346
-8% -$11.1K ﹤0.01% 3332
2017
Q3 		$165K Hold
4,380
– – ﹤0.01% 3125
2017
Q2 		$44K Buy
4,380
+517
+13% +$15.4K ﹤0.01% 3512
2017
Q1 		$133K Buy
3,863
+378
+11% +$13.3K ﹤0.01% 3056
2016
Q4 		$100K Hold
3,485
– – ﹤0.01% 3221
2016
Q3 		$111K Buy
3,485
+393
+13% +$13.3K ﹤0.01% 3166
2016
Q2 		$100K Sell
3,092
-80,991
-96% -$2.71M ﹤0.01% 3210
2016
Q1 		$2.19M Sell
84,083
-5,043
-6% -$110K ﹤0.01% 1381
2015
Q4 		$3.18K Sell
89,126
-4,385
-5% -$154K ﹤0.01% 1255
2015
Q3 		$3.09K Sell
93,511
-85,524
-48% -$3.56M ﹤0.01% 1233
2015
Q2 		$7.5K Buy
179,035
+126,830
+243% +$4.91M 0.01% 844
2015
Q1 		$1.7K Buy
52,205
+1,695
+3% +$58.3K ﹤0.01% 1443
2014
Q4 		$1.6K Sell
50,510
-1,106
-2% -$31.4K ﹤0.01% 1379
2014
Q3 		$1.28K Buy
51,616
+952
+2% +$22.3K ﹤0.01% 1439
2014
Q2 		$1.15M Sell
50,664
-2,776
-5% -$58K ﹤0.01% 1504
2014
Q1 		$1.3K Sell
53,440
-247
-0.5% -$6.25K ﹤0.01% 1476
2013
Q4 		$1.34K Sell
53,687
-935
-2% -$22.1K ﹤0.01% 1453
2013
Q3 		$1.5K Sell
54,622
-302
-0.5% -$6.31K ﹤0.01% 1379
2013
Q2 		$997K Buy
+54,924
New +$757K ﹤0.01% 1472

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ACAD Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Acadia Pharmaceuticals (ACAD) stake by 7.4% in Q1 2026, buying an estimated $938K and bringing the position to 571,776 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #749.

Manulife (Manufacturers Life Insurance) first reported a position in ACAD in Q2 2013 and has held it in 50 quarters since. The position peaked at $26.5M in Q4 2023. 342 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 571,776 shares of Acadia Pharmaceuticals worth $12.7M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 39,243 Acadia Pharmaceuticals shares in Q1 2026, an estimated $938K.
  • Acadia Pharmaceuticals made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #749 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Acadia Pharmaceuticals position peaked at $26.5M in Q4 2023.
  • 342 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.